Standard or custom package
excellent quality and reliable supplier
*The following content is generated by AI and is for reference only.
Overview
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist synthesized via solid-phase peptide synthesis. Its molecular formula is C84H127N21O20, with CAS No. 568092-58-0.
Application
- Pharmaceutical Manufacturing: Bulk API production for type 2 diabetes management.
- Clinical Therapy: Adjunct treatment to diet and exercise for glycemic control.
- Research & Development: Use in metabolic disorder studies and drug efficacy trials.
Precautions
Contraindicated in patients with personal or family history of medullary thyroid carcinoma. Store lyophilized powder at 2°C to 8°C protected from light; reconstituted solutions must be used immediately.